Product Quantum (Rs. Cr) (SEBI) Quantum (Rs. Cr) (Other FSR) Long Term Rating Short Term Rating Regulated By
Bank Loan Ratings 0.00 16.00 ACUITE A+ | Reaffirmed | Rating Watch with Developing Implications - RBI
Bank Loan Ratings 0.00 9.00 - ACUITE A1+ | Reaffirmed | Rating Watch with Developing Implications RBI
Total Outstanding 0.00 25.00 - - -
Total Withdrawn 0.00 0.00 - - -
Note:- For activities or ratings of instruments falling under the purview of Financial Sector Regulators other than SEBI, the grievance / dispute redressal mechanisms and investor protection mechanisms provided by SEBI shall not be available.
 

Rating Rationale

­­Acuité has reaffirmed its long-term rating of ‘ACUITE A+’ (read as ACUITE A Plus) and its short-term rating of 'ACUITE A1+' (read as ACUITE A one Plus)  on the Rs. 25.00 crore bank facilities of Hindustan Composites Limited (HCL). The ratings have been placed under 'Rating Watch with Developing Implications'.

Rationale for placing the rating on watch and reaffirmation
Rating Watch with Developing Implications reflects the proposed transfer of the company's principal operating business undertaking through a slump sale transaction to Rane (Madras) Limited. The proposed transaction is subject to shareholder approval and fulfilment of customary conditions precedent and is expected to be completed within the stipulated timeline. The rating watch reflects the uncertainty regarding the post-transaction business profile of the company, including the utilization of sale proceeds, sustainability of earnings from the continuing businesses, capital allocation strategy and the resultant impact on the company's financial risk profile and liquidity position. At the same time, the transaction could strengthen the company's balance sheet and financial flexibility through the receipt of substantial cash proceeds. Acuite will continue to monitor the progress of the proposed transaction, receipt of requisite approvals, completion of the slump sale and the company's strategy for deployment of the proceeds.

The reaffirmation factors in the healthy performance of the business undertaking proposed to be divested, which has been classified as a discontinued operation and continued to demonstrate improvement in revenue and profitability in FY2026, with the trend continuing in Q1FY27. The rating reaffirmation also factors in HCL's healthy financial risk profile, marked by a strong net worth position, sizeable investment portfolio and strong liquidity. However, the rating remains constrained by the moderately intensive working capital nature of the commodity trading business and the exposure of earnings to volatility in financial markets and investment returns. Going forward, the timely completion of the proposed transaction, utilization of sale proceeds, sustainability of returns from the investment portfolio and the company's ability to maintain a stable earnings and financial risk profile will remain key rating monitorables.


Key Rating Drivers

Rating Sensitivities

Particulars Unit FY 26 (Actual) FY 25 (Actual)
Operating Income Rs. Cr. 375.01 325.08
PAT Rs. Cr. 31.11 35.00
PAT Margin (%) 8.30 10.77
Total Debt/Tangible Net Worth Times 0.00 0.00
PBDIT/Interest Times 189.11 656.14
Note:- For activities or ratings of instruments falling under the purview of Financial Sector Regulators other than SEBI, the grievance / dispute redressal mechanisms and investor protection mechanisms provided by SEBI shall not be available.
­